IDEXX Laboratories Inc. (Nasdaq: IDXX) has developed a diagnostic test to help veterinarians detect kidney injury in cats and dogs at an earlier stage to improve treatment. The Westbrook-based ...
Cancer Dx Panel expansion and inVue Dx FNA cytology rollout advance veterinary cancer care, enabling comprehensive mast cell ...
The launch of the Catalyst® Pancreatic Lipase Test demonstrates IDEXX's Technology for Life strategy and will provide veterinarians with quantitative results at the point-of-care in less than 10 ...
May 1 (Reuters) - Animal diagnostics maker IDEXX Laboratories (IDXX.O), opens new tab on Thursday raised its annual profit forecast after it beat Wall Street estimates for quarterly profit, as it ...
Nov 3 (Reuters) - IDEXX Laboratories (IDXX.O), opens new tab raised its full-year profit and revenue forecasts on Monday and reported better third-quarter results than last year, as the pet ...
Hosted on MSN
IDEXX Laboratories Shares Surge 7% After Beating Q3 Estimates on Strong Diagnostic Demand
IDEXX Laboratories (NASDAQ:IDXX) shares jumped 7.2% on Monday after the animal health diagnostics leader reported third-quarter earnings and revenue that topped Wall Street expectations, supported by ...
IDEXX Laboratories is a leader in animal diagnostics, boasting strong recurring revenue and nearly 50% stock gains year-to-date. IDXX's innovation pipeline, robust cash position, and global reach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results